Retatrutide is an innovative triple?receptor agonist synthetic peptide, targeting GLP?1, GIP and glucagon receptor (GCGR). Unique lipid?chain modification optimizes its half?life performance, which serves as vital research material for pre?clinical metabolic mechanism investigation.

It modulates insulin secretion, glycemic control, appetite regulation and energy expenditure simultaneously. Widely utilized in pre?clinical studies of obesity, type 2 diabetes, lipid metabolism and metabolic dysfunction animal models, applicable for cell?based assays and in?vivo animal experiments.

Our Retatrutide is produced via reliable solid?phase peptide synthesis technology. Every batch is inspected by HPLC and mass spectrometry to guarantee high purity and correct molecular structure. COA document can be provided on request. Lyophilized powder ensures outstanding stability during transit and long?term storage. Multiple packing choices are available, ranging from small laboratory sample vials to bulk kilogram?scale orders.

Warning: This product is exclusively for scientific laboratory research. It shall not be used for human consumption, injection, clinical diagnosis or therapy.

Ready for Gedai chemical website upload. Tell me next peptide name.